Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CAMLG antibody (AA 1-189) (HRP)

This anti-CAMLG antibody is a Rabbit Polyclonal antibody detecting CAMLG in ELISA. Suitable for Human.
Catalog No. ABIN7146313

Quick Overview for CAMLG antibody (AA 1-189) (HRP) (ABIN7146313)

Target

See all CAMLG Antibodies
CAMLG (Calcium Modulating Ligand (CAMLG))

Reactivity

  • 31
  • 9
  • 9
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 30
  • 7
  • 1
Rabbit

Clonality

  • 34
  • 4
Polyclonal

Conjugate

  • 30
  • 3
  • 2
  • 1
  • 1
  • 1
This CAMLG antibody is conjugated to HRP

Application

  • 35
  • 14
  • 11
  • 10
  • 9
  • 8
  • 5
  • 1
ELISA
  • Binding Specificity

    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-189

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human Calcium signal-modulating cyclophilin ligand protein (1-189AA)

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    CAMLG (Calcium Modulating Ligand (CAMLG))

    Alternative Name

    CAMLG

    Background

    Background: Likely involved in the mobilization of calcium as a result of the TCR/CD3 complex interaction. Binds to cyclophilin B.

    Aliases: CAMLG antibody, CAML antibody, Calcium signal-modulating cyclophilin ligand antibody, CAML antibody

    UniProt

    P49069

    Pathways

    EGFR Signaling Pathway
You are here:
Chat with us!